INS and type 1 diabetes mellitus: AKS-107 also bound human polyclonal IAAs in pooled sera (from IAA+ patients with newly diagnosed T1D before exogenous insulin treatment) via an 125I-rhINS competitive radioimmunoassay, demonstrating an affinity similar to that of unlabeled rhINS (Figure 2B).